Bellmann B, Muhle H, Ernst H
Fraunhofer Institute of Toxicology and Aerosol Research, Hannover, Germany.
Environ Health Perspect. 1997 Sep;105 Suppl 5(Suppl 5):1049-52. doi: 10.1289/ehp.97105s51049.
Published i.p. injection studies have shown different biological behavior of different sepiolite samples. There was no evidence for carcinogenic potential of sepiolite from Vicalvaro, Spain, whereas a high tumor incidence was reported for sepiolite from Finland. The low biological activity of the sepiolite from Vicalvaro, compared to the Finnish sample, could be caused by low in vivo persistence or by the short length of the fibers, or both. In this study a further sepiolite sample, obtained as a commercial sample originating from China, was investigated. This sample contained a higher fraction of fibers longer than 5 microns, comparable to the Finnish sepiolite sample. The fraction of fibers with a length > 5 microns was 0.12 and 2.2% for the Vicalvaro and Chinese sepiolite, respectively. For the fiber fraction longer than 8 microns, the corresponding values were 0.0045 and 0.82%. The in vivo persistence of the sepiolite samples from China and Vicalvaro was analyzed after intratracheal instillation of 2 mg in female Wistar rats. Fiber retention in the lungs was analyzed by transmission electron microscopy at different sacrifice dates up to 12 months after application. For the Vicalvaro sepiolite, a splitting of fiber bundles was found during retention time in the lung. Therefore, no half-time of the fiber clearance could be calculated from the number of fibers. The decrease of the calculated retained fiber mass was faster for the Vicalvaro sepiolite (T1/2 = 89 days) compared to the Chinese sepiolite (T1/2 = 129 days). For 2 or 3 rats per group, at sacrifice date 12 months after i.p. injection, the lung was investigated by histopathology. The main difference between both treatment groups was a more pronounced fibrotic response in the Chinese sepiolite-treated rats compared to those treated with Vicalvaro sepiolite. It is concluded that both the higher fraction of long sepiolite fibers and the slower elimination rate of the fiber mass in the Chinese sample were important factors for the different biological reaction in comparison with Vicalvaro sepiolite.
已发表的腹腔注射研究表明,不同的海泡石样品具有不同的生物学行为。没有证据表明来自西班牙维卡尔沃的海泡石具有致癌潜力,而据报道来自芬兰的海泡石肿瘤发病率很高。与芬兰样品相比,维卡尔沃海泡石的低生物活性可能是由于体内持久性低或纤维长度短,或两者兼而有之。在本研究中,对另一个作为源自中国的商业样品获得的海泡石样品进行了研究。该样品含有比5微米长的纤维的比例更高,与芬兰海泡石样品相当。维卡尔沃和中国海泡石中长度大于5微米的纤维比例分别为0.12%和2.2%。对于长度大于8微米的纤维部分,相应的值分别为0.0045%和0.82%。在雌性Wistar大鼠气管内滴注2毫克后,分析了来自中国和维卡尔沃的海泡石样品的体内持久性。在应用后长达12个月的不同处死日期,通过透射电子显微镜分析肺中的纤维保留情况。对于维卡尔沃海泡石,在肺中保留期间发现纤维束分裂。因此,无法根据纤维数量计算纤维清除的半衰期。与中国海泡石(T1/2 = 129天)相比,维卡尔沃海泡石(T1/2 = 89天)计算出的保留纤维质量的下降更快。每组2或3只大鼠,在腹腔注射后12个月的处死日期,通过组织病理学检查肺。两个治疗组之间的主要区别是,与用维卡尔沃海泡石治疗的大鼠相比,用中国海泡石治疗的大鼠的纤维化反应更明显。得出的结论是,与维卡尔沃海泡石相比,中国样品中较长海泡石纤维的比例较高以及纤维质量的消除速度较慢是导致不同生物学反应的重要因素。